REFERENCES

• HeuserI.Depression, endocrinologically a syndrome of premature aging?Maturitas.200241(suppl 1)S19S2311955792
   PubMed Web of Science ®Google Scholar
• McIntyreRS.SoczynskaJK.KonarskiJZ.et al.Should depressive syndromes be reclassified as "metabolic syndrome type II"?Ann Clin Psychiatry.20071925726418058283
   PubMedGoogle Scholar
• EvansDL.CharneyDS.LewisL.et al.Mood disorders in the medically ill: scientific review and recommendations.Biol Psychiatry.20055817518916084838
   PubMed Web of Science ®Google Scholar
• SchulzR.BeachSR.IvesDG.MartireLM.AriyoAA.KopWJ.Association between depression and mortality in older adults: the Cardiovascular Health Study.Arch Intern Med.20001601761176810871968
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.EpelES.MellonS.When blue turns to grey: do stress and depression accelerate cell aging?World J Biol Psychiatry.200892518273736
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.EpelES.ReusVI.MellonSH.Depression gets old fast: do stress and depression accelerate cell aging?Depression and Anxiety.20102732733820376837
   PubMed Web of Science ®Google Scholar
• EpelES.Psychological and metabolic stress: a recipe for accelerated cellular aging?Hormones (Athens).2009872219269917
   PubMedGoogle Scholar
• EpelES.BlackburnEH.LinJ.et al.Accelerated telomere shortening in response to life stress.Proc Natl Acad Sci USA.2004101173121731515574496
   PubMed Web of Science ®Google Scholar
• EpelES.LinJ.WilhelmFH.et al.Cell aging in relation to stress arousal and cardiovascular disease risk factors.Psychoneuroendocrinology.20063127728716298085
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.EpelES.ReusVI.Stress hormone-related psychopathology: pathophysiological and treatment implications.World J Biol Psychiat.20012115143
   PubMedGoogle Scholar
• SelyeH.The Stress of Life. New York, NY: McGraw-Hill.1956
   Google Scholar
• SeemanT.McEwenBS.RoweJ.SingerB.Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging.Proc Natl Acad Sci USA.200194770477511287659
   PubMedGoogle Scholar
• McEwenB.Allostasis and allostatic load: implications for neuropsychopharmacology.Neuropsychopharmacology.20002210812410649824
   PubMed Web of Science ®Google Scholar
• SchulkinJ.McEwenBS.GoldPW.Allostasis, amygdala, and anticipatory angst.Neurosci Biobehav Rev.1994183853967984356
   PubMed Web of Science ®Google Scholar
• WongML.KlingMA.MunsonPJ.et al.Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.Proc Natl Acad Sci USA.20009732533010618417
   PubMed Web of Science ®Google Scholar
• SapolskyRM.The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death.Biol Psychiatry.20004875576511063972
   PubMed Web of Science ®Google Scholar
• ManingerN.WolkowitzOM.ReusVI.EpelES.MellonSH.Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).Front Neuroendocrinol.200930659119063914
   PubMed Web of Science ®Google Scholar
• PatchevVK.HassanAH.HolsboerDF.AlmeidaOF.The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus.Neuropsychopharmacology.1996155335408946427
   PubMed Web of Science ®Google Scholar
• KendlerK.KarkowskiLM.PrescottCA.Causal relationship between stressful life events and the onset of major depression.Am J Psychiatry.199915683784110360120
   PubMed Web of Science ®Google Scholar
• RaisonCL.MillerAH.When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.Am J Psychiatry.20031601554156512944327
   PubMed Web of Science ®Google Scholar
• FolkmanS.LazarusRS.Dunkel-SchetterC.DeLongisA.GruenRJ.Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes.J Pers Soc Psychol.19865099210033712234
   PubMed Web of Science ®Google Scholar
• O'DonovanA.LinJ.DhabharFS.et al.Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women.Brain Behav Immun.20092344644919111922
   PubMed Web of Science ®Google Scholar
• DensonTF.SpanovicM.MillerN.Cognitive appraisals and emotions predict cortisol and immune responses: a meta-analysis of acute laboratory social stressors and emotion inductions.Psychol Bull.200913582385319883137
   PubMed Web of Science ®Google Scholar
• StowellJR.Kiecolt-GlaserJK.GlaserR.Perceived stress and cellular immunity: when coping counts.J Behav Med.20012432333911523331
   PubMed Web of Science ®Google Scholar
• LyonsDM.BuckmasterPS.LeeAG.et al.Stress coping stimulates hippocampal neurogenesis in adult monkeys.Proc Natl Acad Sci USA.2010107148231482720675584
   PubMed Web of Science ®Google Scholar
• TaylorSE.BurklundLJ.EisenbergerNI.et al.Neural bases of moderation of cortisol stress responses by psychosocial resources.J Pers Soc Psychol.20089519721118605860
   PubMed Web of Science ®Google Scholar
• BreierA.Kelsoe JRJr.KirwinPD.et al.Early parental loss and development of adult psychopathology.Arch Gen Psychiatry.1988459879932972265
   PubMed Web of Science ®Google Scholar
• FederA.NestlerEJ.CharneyDS.Psychobiology and molecular genetics of resilience.Nat Rev Neurosci.20091044645719455174
   PubMed Web of Science ®Google Scholar
• ChapmanDP.WhitfieldCL.FelittiVJ.et al.Adverse childhood experiences and the risk of depressive disorders in adulthood.J Affect Disord.20048221722515488250
   PubMed Web of Science ®Google Scholar
• HeimC.PlotskyPM.NemeroffCB.Importance of studying the contributions of early adverse experience to neurobiological findings in depression.Neuropsychopharmacology.20042964164815034558
   PubMed Web of Science ®Google Scholar
• Grassi-OliveiraR.AshyM.SteinLM.Psychobiology of childhood maltreatment: effects of allostatic load?Rev Bras Psiquiatr.200830606818373020
   PubMed Web of Science ®Google Scholar
• VythilingamM.HeimC.NewportJ.et al.Childhood trauma associated with smaller hippocampal volume in women with major depression.Am J Psychiatry.20021592072208012450959
   PubMed Web of Science ®Google Scholar
• MillerJM.KinnallyEL.OgdenRT.et al.Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.Synapse.20096356557319288578
   PubMed Web of Science ®Google Scholar
• AndaRF.FelittiVJ.BremnerJD.et al.The enduring effects of abuse and related adverse experiences in childhood: A convergence of evidence from neurobiology and epidemiology.Eur Arch Psychiatry Clin Neurosci.200625617418616311898
   PubMed Web of Science ®Google Scholar
• PaceTW.MletzkoTC.AlagbeO.et al.Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.Am J Psychiatry.20061631630163316946190
   PubMed Web of Science ®Google Scholar
• Kiecolt-GlaserJK.GouinJP.WengNP.et al.Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation.Psychosom Med201073162221148804
   PubMed Web of Science ®Google Scholar
• BarnesSK.OzanneSE.Pathways linking the early environment to longterm health and lifespan.Prog Biophys Mol Biol. In press.
   Google Scholar
• RothTL.LubinFD.FunkAJ.SweattJD.Lasting epigenetic influence of early-life adversity on the BDNF gene.Biol Psychiatry.20096576076919150054
   PubMed Web of Science ®Google Scholar
• AvitalA.RamE.MaayanR.WeizmanA.Richter-LevinG.Effects of early-life stress on behavior and neurosteroid levels in the rat hypothalamus and entorhinal cortex.Brain Res Bull.20066841942416459196
   PubMed Web of Science ®Google Scholar
• ThomasC.HypponenE.PowerC.Obesity and type 2 diabetes risk in midadult life: the role of childhood adversity.Pediatrics.2008121e1240e124918450866
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.EpelES.MellonSH.et al.Major depression and history of childhood sexual abuse are related to increased PBMC telomerase activity. in International Society of Psychoneuroendocrinology Annual Meeting. San Francisco, CA. 2009
   Google Scholar
• KananenL.SurakkaI.PirkolaS.et al.Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls.PLoS One.20105e1082620520834
   PubMed Web of Science ®Google Scholar
• TyrkaAR.PriceLH.KaoHT.PortonB.MarsellaSA.CarpenterLL.Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging.Biol Psychiatry.20106753153419828140
   PubMed Web of Science ®Google Scholar
• O'DonovanAEpelES.LinJ.et al.Childhood trauma associated with short leukocyte telomere length in post-traumatic stress disorder.Biol Psychiatry. In press.2011
   Web of Science ®Google Scholar
• McGowanPO.SasakiA.DAlessioAC.et al.Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.Nat Neurosci.20091234234819234457
   PubMed Web of Science ®Google Scholar
• WeaverIC.CervoniN.ChampagneFA.et al.Epigenetic programming by maternal behavior.Nat Neurosci.2004784785415220929
   PubMed Web of Science ®Google Scholar
• KrishnanV.NestlerEJ.Linking molecules to mood: new insight into the biology of depression.Am J Psychiatry.20101671305132020843874
   PubMed Web of Science ®Google Scholar
• DeRijkR.de KloetER.Corticosteroid receptor genetic polymorphisms and stress responsivity.Endocrine.20052826327016388115
   PubMed Web of Science ®Google Scholar
• WassermanD.WassermanJ.SokolowskiM.Genetics of HPA-axis, depression and suicidality.Eur Psychiatry.20102527828020444578
   PubMed Web of Science ®Google Scholar
• SchroederM.KrebsMO.BleichS.FrielingH.Epigenetics and depression: current challenges and new therapeutic options.Curr Opin Psychiatry.20102358859220644477
   PubMed Web of Science ®Google Scholar
• KorosiA.ShanabroughM.McLellandS.et al.Early-life experience reduces excitation to stress-responsive hypothalamic neurons and reprograms the expression of corticotropin-releasing hormone.J Neurosci.20103070371320071535
   PubMed Web of Science ®Google Scholar
• MurgatroydC.PatchevAV.WuY.et al.Dynamic DNA methylation programs persistent adverse effects of early-life stress.Nat Neurosci.2009121559156619898468
   PubMed Web of Science ®Google Scholar
• OberlanderTF.WeinbergJ.PapsdorfM.GrunauR.MisriS.DevlinAM.Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses.Epigenetics.200839710618536531
   PubMed Web of Science ®Google Scholar
• TyrkaAR.PriceLH.GelernterJ.SchepkerC.AndersonGM.CarpenterLL.Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.Biol Psychiatry.20096668168519596121
   PubMed Web of Science ®Google Scholar
• ChipmanP.JormAF.TanXY.EastealS.No association between the serotonin-1A receptor gene single nucleotide polymorphism rs6295C/G and symptoms of anxiety or depression, and no interaction between the polymorphism and environmental stressors of childhood anxiety or recent stressful life events on anxiety or depression.Psychiatr Genet.201020813
   Web of Science ®Google Scholar
• CaspiA.SugdenK.MoffittTE.et al.Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.Science.200330138638912869766
   PubMed Web of Science ®Google Scholar
• KargK.BurmeisterM.SheddenK.SenS.The Serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.Arch Gen Psychiatry. In press.
   Google Scholar
• RischN.HerrellR.LehnerT.et al.Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.JAMA.20093012462247119531786
   PubMed Web of Science ®Google Scholar
• ResslerKJ.BradleyB.MercerKB.et al.Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms.Am J Med Genet B Neuropsychiatr Genet.2010153B81282420029939
   PubMed Web of Science ®Google Scholar
• KaufmanJ.YangBZ.Douglas-PalumberiH.et al.Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.Biol Psychiatry.2006596738016458264
   PubMed Web of Science ®Google Scholar
• FriesE.HesseJ.HellhammerJ.HellhammerDH.A new view on hypocortisolism.Psychoneuroendocrinology.2005301010101615950390
   PubMed Web of Science ®Google Scholar
• BremmerMA.DeekDJ.BeekmanAT.PenninxBW.LipsP.HoogendijkWJ.Major depression in late life is associated with both hypo- and hypercortisolemia.Biol Psychiatry.20076247948617481591
   PubMed Web of Science ®Google Scholar
• MillerAH.Letter to the Editor Re: An inflammatory review of glucocorticoids in the CNS. Sorrells SF, Sapolsky RM.Brain Behavior Immun.200721259272988989; author reply 990.
   PubMed Web of Science ®Google Scholar
• SorrellsSF.SapolskyRM.A pro-inflammatory review of glucocorticoid actions in the CNS.Brain Behav Immun.20072125927217194565
   PubMed Web of Science ®Google Scholar
• MillerKB.NelsonJC.Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?Arch Gen Psychiatry.1987447697743632250
   PubMed Web of Science ®Google Scholar
• AranaGW.SantosAB.LaraiaMT.et al.Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial.Am J Psychiatry.19951522652677840362
   PubMed Web of Science ®Google Scholar
• BelanoffJ.SchatzbergAF.Glucocorticoid antagonists.Neuropsychopharmacology.200023S56
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.ReusVI.Treatment of depression with antiglucocorticoid drugs.Psychosomat Med.199961698711
   PubMed Web of Science ®Google Scholar
• GallagherP.WatsonS.SmithMS.YoungAH.FerrierIN.Antiglucocorticoid treatments for mood disorders.Cochrane Database Syst Rev.2008CD005168
   PubMed Web of Science ®Google Scholar
• FrankMG.MiguelZD.WatkinsLR.MaierSF.Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide.Brain Behav Immun.201024193019647070
   PubMed Web of Science ®Google Scholar
• BardenN.ReulJM.HolsboerF.Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?Trends Neurosci.1995186117535490
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.BurkeH.EpelES.ReusVI.Glucocorticoids: mood, memory and mechanisms.Ann NY Acad Sci.20091179194019906230
   PubMed Web of Science ®Google Scholar
• ReusVI.MinerC.Evidence for physiological effects of hypercortisolemia in psychiatric patients.Psychiatry Res.19851447563857648
   PubMed Web of Science ®Google Scholar
• DumanRS.MonteggiaLM.A neurotrophic model for stress-related mood disorders.Biol Psychiatry.2006591116112716631126
   PubMed Web of Science ®Google Scholar
• HeimC.EhlertU.HellhammerDH.The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders.Psychoneuroendocrinology.20002513510633533
   PubMed Web of Science ®Google Scholar
• UzunovaV.ShelineY.DavisJM.et al.Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.Proc Natl Acad Sci USA.199895323932449501247
   PubMed Web of Science ®Google Scholar
• GriffinLD.MellonSH.Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.Proc Natl Acad Sci.199996135121351710557352
   PubMed Web of Science ®Google Scholar
• GuidottiA.CostaE.Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain allopregnanolone availability?Biol Psychiatry.1998448658739807641
   PubMed Web of Science ®Google Scholar
• BauerME.Chronic stress and immunosenescence: a review.Neuroimmunomodulation.20081524125019047801
   PubMed Web of Science ®Google Scholar
• ZampieriS.MellonSH.ButtersTD.et al.Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone.J Cell Mol Med.200133786379618774957
   PubMed Web of Science ®Google Scholar
• WangJM.IrwinRW.LiuL.ChenS.BrintonRD.Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.Curr Alzheimer Res.2007451051718220513
   PubMed Web of Science ®Google Scholar
• StrohleA.RomeoE.HermannB.et al.Concentrations of 3a-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.Biol Psychiatry.19994527427710023501
   PubMed Web of Science ®Google Scholar
• RupprechtR.Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.Psychoneuroendocrinology.20032813916812510009
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.ReusVI.Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression.World J Biol Psychiatry.200349810212872201
   PubMed Web of Science ®Google Scholar
• BarbacciaML.SerraM.PurdyRH.BiggioG.Stress and neuroactive steroids.Int Rev Neurobiol.20014624327211599302
   PubMed Web of Science ®Google Scholar
• CalogeroAE.PalumboMA.BosboomAM.et al.The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor.J Endocrinol.19981581211259713333
   PubMed Web of Science ®Google Scholar
• PatchevVK.ShoaibM.HolsboerF.AlmeidaOF.The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormoneinduced anxiety and alters the release and gene expression of corticotropinreleasing hormone in the rat hypothalamus.Neuroscience.1994622652717816204
   PubMed Web of Science ®Google Scholar
• PatchevVK.MontkowskiA.RouskovaD.et al.Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events.J Clin Invest.1997999629669062354
   PubMed Web of Science ®Google Scholar
• DongE.MatsumotoK.UzunovG.et al.Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation.Proc Natl Acad Sci USA.2001982849285411226329
   PubMed Web of Science ®Google Scholar
• KlatzkinRR.MorrowAL.LightKC.PedersenCA.GirdlerSS.Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women.Biol Psychol.20067121115951099
   PubMed Web of Science ®Google Scholar
• RapkinAJ.MorganM.GoldmanL.et al.Progesterone metabolite allopregnanolone in women with premenstrual syndrome.Obstet Gynecol.1997907097149351749
   PubMed Web of Science ®Google Scholar
• SundströmI.AnderssonA.NybergS.et al.Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.Neuroendocrinology.1998671261389508043
   PubMed Web of Science ®Google Scholar
• HenningsJM.IsingM.GrautoffS.et al.Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls.Exp Clin Endocrinol Diabetes.20101189810019834872
   PubMed Web of Science ®Google Scholar
• KopfD.WestphalS.LuleyCW.et al.Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.J Clin Psychopharmacol.20042452753115349009
   PubMed Web of Science ®Google Scholar
• Weber-HamannB.HentschelF.KniestA.et al.Hypercortisolemic depression is associated with increased intra-abdominal fat.Psychosom Med.20026427427711914443
   PubMed Web of Science ®Google Scholar
• VogelzangsN.SuthersK.FerrucciL.et al.Hypercortisolemic depression is associated with the metabolic syndrome in late-life.Psychoneuroendocrinology.20073215115917224244
   PubMed Web of Science ®Google Scholar
• de LeonMJ.McRaeT.RusinekH.et al.Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.J Clin Endocrinol Metab.199782325132599329348
   PubMed Web of Science ®Google Scholar
• McIntyreRS.SoczynskaJZ.LewisGF.et al.Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.Expert Opin Pharmacother.200671305132116805717
   PubMedGoogle Scholar
• RasgonNL.KennaHA.Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.Neurobiol Aging.200526 Suppl 110310716225963
   PubMed Web of Science ®Google Scholar
• AvogaroA.de KreutzenbergSV.FadiniGP.Insulin signaling and life span.Pflugers Arch.201045930131419756720
   PubMed Web of Science ®Google Scholar
• GardnerJP.SrinivasanSR.ChenW.et al.Rise in insulin resistance is associated with escalated telomere attrition.Circulation.20051112171217715851602
   PubMed Web of Science ®Google Scholar
• AlvehusM.BurenJ.SjostromM.GoedeckeJ.OlssonT.The human visceral fat depot has a unique inflammatory profile.Obesity (Silver Spring).20101887988320186138
   PubMed Web of Science ®Google Scholar
• PalmieriVO.GrattaglianoI.PortincasaP.PalascianoG.Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome.J Nutr.20061363022302617116714
   PubMed Web of Science ®Google Scholar
• BauerME.JeckelCM.LuzC.The role of stress factors during aging of the immune system.Ann N Y Acad Sci.2009115313915219236337
   PubMed Web of Science ®Google Scholar
• Kiecolt-GlaserJ.K.GlaserR.Depression and immune function: central pathways to morbidity and mortality.J Psychosom Res.20025387387612377296
   PubMed Web of Science ®Google Scholar
• DhabharFS.BurkeHM.EpelES.et al.Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.J Psychiatr Res.20094396296919552919
   PubMed Web of Science ®Google Scholar
• DowlatiY.HermannN.SwardfagerW.et al.A meta-analysis of cytokines in major depression.Biol Psychiatry.20106744645720015486
   PubMed Web of Science ®Google Scholar
• KaurK.SharmaAK.DhingraS.SingalPK.Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes.J Mol Cell Cardiol.2006411023103017045606
   PubMed Web of Science ®Google Scholar
• PickeringM.O'ConnorJ.J.Pro-inflammatory cytokines and their effects in the dentate gyrus.Prog Brain Res.200716333935417765728
   PubMed Web of Science ®Google Scholar
• MillerAH.MaleticV.RaisonCL.Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.Biol Psychiatry.20096573274119150053
   PubMed Web of Science ®Google Scholar
• MarslandAL.GianarosPJ.AbramowitchSM.ManuckSB.HaririAR.Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults.Biol Psychiatry.20086448449018514163
   PubMed Web of Science ®Google Scholar
• CarreroJJ.StenvinkelP.FellströmB.et al.Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.J Intern Med.200826330231218070000
   PubMed Web of Science ®Google Scholar
• EffrosRB.Kleemeier Award Lecture. 2008--the canary in the coal mine: telomeres and human healthspan.J Gerontol A Biol Sci Med Sci.20096451151519228779
   PubMed Web of Science ®Google Scholar
• IrieM.MiyataM.KasaiH.Depression and possible cancer risk due to oxidative DNA damage.J Psychiatr Res.20053955356016005897
   PubMed Web of Science ®Google Scholar
• JosephJA.Shukitt-HaleB.CasadesusG.FisherD.Oxidative stress and inflammation in brain aging: nutritional considerations.Neurochem Res.20053092793516187227
   PubMed Web of Science ®Google Scholar
• ForlenzaMJ.MillerGE.Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression.Psychosom Med.2006681716449405
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.MellonSH.EpelES.et al.Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress - preliminary findings.PLoS One. In press.2011
   PubMed Web of Science ®Google Scholar
• TsirpanlisG.ChatzipanagiotouS.BoufidouF.et al.Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.Nephrology (Carlton).20061150650917199788
   PubMed Web of Science ®Google Scholar
• GrantMM.BarberVS.GriffithsHR.The presence of ascorbate induces expression of brain derived neurotrophic factor in SH-SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival.Proteomics.2005553454015627972
   PubMed Web of Science ®Google Scholar
• CumurcuBE.OzyurtH.EtikanI.DemirS.KarlidagR.Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment.Psychiatry Clin Neurosci.20096363964519674383
   PubMed Web of Science ®Google Scholar
• GrovesJO.Is it time to reassess the BDNF hypothesis of depression?Mol Psychiatry.2007121079108817700574
   PubMed Web of Science ®Google Scholar
• ChenB.DowlatshahiD.MacQueenGM.WangJ.-F.YoungLT.Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.Biol Psychiatry.20015026026511522260
   PubMed Web of Science ®Google Scholar
• Bocchio-ChiavettoL.BagnardiV.ZanardiniR.et al.Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.World J Biol Psychiatry20101176377320334574
   PubMed Web of Science ®Google Scholar
• SchmidtHD.DumanRS.Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.Neuropsychopharmacology.2010352378239120686454
   PubMed Web of Science ®Google Scholar
• SantarelliL.SaxeM.GrossC.et al.Requirement of hippocampal neurogenisis for the behavioral effects of antidepressants.Science.200330180580912907793
   PubMed Web of Science ®Google Scholar
• Ibarguen-VargasY.SurgetA.ToumaC.et al.Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress.Behav Brain Res.200920224525119463708
   PubMed Web of Science ®Google Scholar
• JoostenEA.HouwelingDA.Local acute application of BDNF in the lesioned spinal cord anti-inflammatory and anti-oxidant effects.Neuroreport.2004151163116615129166
   PubMed Web of Science ®Google Scholar
• FuW.LuC.MattsonMP.Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons.J Neurosci.200222107101071912486164
   PubMed Web of Science ®Google Scholar
• ChaldakovGN.TonchevAB.ManniL.et al.Comment on: Krabbe KS, Nielsen AR, Krogh-Madsen R et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.Diabetologia.2007504314381781178217151862
   PubMed Web of Science ®Google Scholar
• KrabbeKS.NielsenAR.Krogh-MadsenR.et al.Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 200750431438
   Google Scholar
• BlackburnEH.GreiderCW.SzostakJW.Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.Nat Med.2006121133113817024208
   PubMed Web of Science ®Google Scholar
• AvivA.Telomeres and human aging: facts and fibs.Sci Aging Knowledge Environ.200451pe4315618136
   PubMedGoogle Scholar
• SimonNM.SmollerJW.McNamaraKL.et al.Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.Biol Psychiatry.20066043243516581033
   PubMed Web of Science ®Google Scholar
• LungFW.ChenNC.ShuBC.Genetic pathway of major depressive disorder in shortening telomeric length.Psychiatr Genet.20071719519917417064
   PubMed Web of Science ®Google Scholar
• HartmannN.BoehnerM.GroenenF.KalbR.Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease.Depress Anxiety.2010271111111621053332
   PubMed Web of Science ®Google Scholar
• EpelES.MerkinSS.CawthonR.et al.The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men.Aging.20091818820195384
   PubMedGoogle Scholar
• CawthonRM.SmithKR.O'BrienE.SivatchenkoA.KerberRA.Association between telomere length in blood and mortality in people aged 60 years or older.Lancet.200336139339512573379
   PubMed Web of Science ®Google Scholar
• DamjanovicAK.YangY.GlaserR.et al.Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients.J Immunol.20071794249425417785865
   PubMed Web of Science ®Google Scholar
• WolkowitzOM.MellonSH.EpelES.et al.Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.Mol Psychiatry. In press.2011
   Google Scholar
• ChoiJ.FauceSR.EffrosRB.Reduced telomerase activity in human T lymphocytes exposed to cortisol.Brain Behav Immun.20082260060518222063
   PubMed Web of Science ®Google Scholar
• LiuJP.ChenSM.CongYS.et al.Regulation of telomerase activity by apparently opposing elements.Ageing Res Rev.2010924525620362078
   PubMed Web of Science ®Google Scholar
• EpelE.DaubenmierJ.MoskowitzJT.FolkmanS.BlackburnE.Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres.Ann N Y Acad Sci.20091172345319735238
   PubMed Web of Science ®Google Scholar
• MattsonMP.DuanW.WanR.GuoZ.Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations.NeuroRx.2004111111615717011
   PubMedGoogle Scholar
• SpiresTL.HannanAJ.Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture, delivered on 27 June, 2004 at the 29th FEBS Congress in Warsaw.Febs J.20052722347236115885086
   PubMed Web of Science ®Google Scholar
• MaesM.YirmyiaR.NorabergJ.et al.The inflammatory neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.Metab Brain Dis.200924275319085093
   PubMed Web of Science ®Google Scholar
• McIntyreRS.SoczynskaJK.WoldeyohannesHO.et al.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Expert Opin Pharmacother.200781615162817685880
   PubMed Web of Science ®Google Scholar
• SanacoraG.ZarateCA.KrystalJH.ManjiHK.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.Nat Rev Drug Discov.2008742643718425072
   PubMed Web of Science ®Google Scholar
• PaulIA.Antidepressant activity and calcium signaling cascades.Hum Psychopharmacol.200116718012404601
   PubMed Web of Science ®Google Scholar
• Berthold-LoslebenM.HeitmannS.HimmerichH.Anti-inflammatory drugs in psychiatry.Inflamm Allergy Drug Targets.2009826627619754410
   PubMedGoogle Scholar
• BerkM.CopolovDL.DeanO.et al.N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial.Biol Psychiatry.20086446847518534556
   PubMed Web of Science ®Google Scholar
• ZhangY.PardridgeWM.Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.Brain Res.2001889495611166685
   PubMed Web of Science ®Google Scholar
• EffrosRB.Telomerase induction in T cells: A cure for aging and disease?Exp Gerontol.20074241642017182206
   PubMed Web of Science ®Google Scholar
• HarleyCB.LiuW.BlascoM.et al.A natural product telomerase activator as part of a health maintenance program.Rejuvenation Res. In press.
   Google Scholar
• OrnishD.ScherwitzLW.DoodyRS.et al.Effects of stress managment training and dietary changes in treating ischemic heart disease.JAMA.198324954596336794
   PubMed Web of Science ®Google Scholar
• HajkovaP.Epigenetic reprogramming-taking a lesson from the embryo.Curr Opin Cell Biol.20102234235020537882
   PubMed Web of Science ®Google Scholar
• WeaverIC.ChampagneFA.BrownSE.et al.Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life.J Neurosci.200525110451105416306417
   PubMed Web of Science ®Google Scholar
• HolsboerF.IsingM.Central CRH system in depression and anxietyevidence from clinical studies with CRH1 receptor antagonists.Eur J Pharmacol.200858335035718272149
   PubMed Web of Science ®Google Scholar
• CocchiP.SilenziM.CalabriG.SalviG.Antidepressant effect of vitamin C.Pediatrics.1980658628637367105
   PubMed Web of Science ®Google Scholar